GeneDx Holdings (WGS) Short-term Investments (2023 - 2026)

GeneDx Holdings (WGS) has 4 years of Short-term Investments data on file, last reported at $76.8 million in Q1 2026.

• Short-term Investments for Q1 2026 came in at $76.8 million, up 29.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.8 million (up 29.11% YoY), and the FY2025 annual result was $66.3 million, up 18.42% from the prior year.
• Short-term Investments climbed to $76.8 million in Q1 2026 per WGS's latest filing, from $66.3 million in the prior quarter.
• Over five years, Short-term Investments peaked at $76.8 million in Q1 2026 and troughed at $12.1 million in Q1 2023.
• A 4-year average of $48.8 million and a median of $57.3 million in 2024 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2024 and 2025: Short-term Investments surged 140.77% in 2024, then grew 0.93% in 2025.
• A 4-year view of Short-term Investments shows it stood at $30.5 million in 2023, then jumped by 83.72% to $56.0 million in 2024, then rose by 18.42% to $66.3 million in 2025, then grew by 15.8% to $76.8 million in 2026.
• Business Quant data shows WGS's Short-term Investments at $76.8 million in Q1 2026, $66.3 million in Q4 2025, and $59.1 million in Q3 2025.